|
|
| Phases of Development | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Cancer | 2 | 0 | 0 | 0 | 0 | | Cardiovascular | 0 | 0 | 0 | 0 | 1 | | Diagnostic | 0 | 0 | 0 | 0 | 1 | | Endocrine / Metabolic | 0 | 1 | 1 | 1 | 11 | | Genitourinary | 2 | 0 | 1 | 1 | 0 | | Inflammation | 0 | 1 | 0 | 0 | 0 | | Musculoskeletal | 0 | 0 | 0 | 0 | 4 | | Neurology | 0 | 1 | 0 | 0 | 1 | | Other | 0 | 0 | 0 | 0 | 1 |
|
|
Products Targeting Progesterone receptor